Header Logo

Connection

JULIE GASTIER-FOSTER to Adult

Back to Details
This is a "connection" page, showing publications JULIE GASTIER-FOSTER has written about Adult.
JULIE GASTIER-FOSTER
Connection Strength
0.507
Adult
  1. Expanding the spectrum of CEP55-associated disease to viable phenotypes. Am J Med Genet A. 2020 05; 182(5):1201-1208.
    View in: PubMed
    Score: 0.042
  2. The Immune Landscape of Cancer. Immunity. 2018 04 17; 48(4):812-830.e14.
    View in: PubMed
    Score: 0.037
  3. Microarray comparative genomic hybridization and cytogenetic characterization of tissue-specific mosaicism in three patients. Am J Med Genet A. 2012 Aug; 158A(8):1924-33.
    View in: PubMed
    Score: 0.025
  4. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 02; 171(4):950-965.e28.
    View in: PubMed
    Score: 0.018
  5. Genomic characterization of cervical lymph node metastases in papillary thyroid carcinoma following the Chornobyl accident. Nat Commun. 2024 Jun 13; 15(1):5053.
    View in: PubMed
    Score: 0.014
  6. Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group. J Clin Oncol. 2024 Jan 10; 42(2):218-227.
    View in: PubMed
    Score: 0.013
  7. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma. Blood. 2023 02 23; 141(8):904-916.
    View in: PubMed
    Score: 0.013
  8. Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232. Leukemia. 2022 03; 36(3):648-655.
    View in: PubMed
    Score: 0.012
  9. Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident. Science. 2021 05 14; 372(6543).
    View in: PubMed
    Score: 0.011
  10. The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study. J Natl Cancer Inst. 2021 01 04; 113(1):27-37.
    View in: PubMed
    Score: 0.011
  11. Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia. Nat Cancer. 2020 11; 1(11):1113-1127.
    View in: PubMed
    Score: 0.011
  12. Diverse deletions in the growth hormone receptor gene cause growth hormone insensitivity syndrome. Hum Mutat. 2000 Oct; 16(4):323-33.
    View in: PubMed
    Score: 0.011
  13. Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes. Nat Genet. 2020 08; 52(8):800-810.
    View in: PubMed
    Score: 0.011
  14. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma. JAMA Oncol. 2020 05 01; 6(5):724-734.
    View in: PubMed
    Score: 0.011
  15. Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report. J Clin Oncol. 2019 10 20; 37(30):2769-2777.
    View in: PubMed
    Score: 0.010
  16. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet. 2019 02; 51(2):296-307.
    View in: PubMed
    Score: 0.010
  17. Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood. 2019 03 21; 133(12):1313-1324.
    View in: PubMed
    Score: 0.010
  18. Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization. J Clin Oncol. 2018 10 10; 36(29):2926-2934.
    View in: PubMed
    Score: 0.009
  19. Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622. J Clin Oncol. 2018 08 01; 36(22):2306-2314.
    View in: PubMed
    Score: 0.009
  20. Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group (COG). Leukemia. 2018 06; 32(6):1370-1379.
    View in: PubMed
    Score: 0.009
  21. The Integrated Genomic Landscape of Thymic Epithelial Tumors. Cancer Cell. 2018 02 12; 33(2):244-258.e10.
    View in: PubMed
    Score: 0.009
  22. Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients. Int J Cancer. 2018 04 15; 142(8):1594-1601.
    View in: PubMed
    Score: 0.009
  23. Genomic analysis of adult B-ALL identifies potential markers of shorter survival. Leuk Res. 2017 05; 56:44-51.
    View in: PubMed
    Score: 0.008
  24. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017 02 13; 31(2):181-193.
    View in: PubMed
    Score: 0.008
  25. Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group. Clin Cancer Res. 2016 Nov 15; 22(22):5582-5591.
    View in: PubMed
    Score: 0.008
  26. Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232. J Clin Oncol. 2016 07 10; 34(20):2380-8.
    View in: PubMed
    Score: 0.008
  27. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28; 164(3):550-63.
    View in: PubMed
    Score: 0.008
  28. Clinical Application of Prognostic Gene Expression Signature in Fusion Gene-Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group. Clin Cancer Res. 2015 Oct 15; 21(20):4733-9.
    View in: PubMed
    Score: 0.008
  29. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. J Natl Cancer Inst. 2015 Dec; 107(12):djv279.
    View in: PubMed
    Score: 0.008
  30. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015 Jun 25; 372(26):2481-98.
    View in: PubMed
    Score: 0.008
  31. Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested? Bone Marrow Transplant. 2015 Sep; 50(9):1173-9.
    View in: PubMed
    Score: 0.007
  32. Germline TP53 variants and susceptibility to osteosarcoma. J Natl Cancer Inst. 2015 Jul; 107(7).
    View in: PubMed
    Score: 0.007
  33. IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients. Blood. 2015 May 28; 125(22):3501-8.
    View in: PubMed
    Score: 0.007
  34. Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434. Pediatr Blood Cancer. 2015 Jul; 62(7):1176-83.
    View in: PubMed
    Score: 0.007
  35. A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults. Blood. 2015 Jan 22; 125(4):680-6.
    View in: PubMed
    Score: 0.007
  36. Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4. J Clin Oncol. 2014 Dec 01; 32(34):3874-82.
    View in: PubMed
    Score: 0.007
  37. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014 Sep 11; 371(11):1005-15.
    View in: PubMed
    Score: 0.007
  38. Multigeneration family with short stature, developmental delay, and dysmorphic features due to 4q27-q28.1 microdeletion. Eur J Med Genet. 2013 Sep; 56(9):521-5.
    View in: PubMed
    Score: 0.007
  39. Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nat Genet. 2013 Jul; 45(7):799-803.
    View in: PubMed
    Score: 0.007
  40. Neurodevelopmental disorders among individuals with duplication of 4p13 to 4p12 containing a GABAA receptor subunit gene cluster. Eur J Hum Genet. 2014 Jan; 22(1):105-9.
    View in: PubMed
    Score: 0.007
  41. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 05 30; 368(22):2059-74.
    View in: PubMed
    Score: 0.006
  42. Impaired regeneration in LGMD2A supported by increased PAX7-positive satellite cell content and muscle-specific microrna dysregulation. Muscle Nerve. 2013 May; 47(5):731-9.
    View in: PubMed
    Score: 0.006
  43. PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report. Pediatr Blood Cancer. 2013 Sep; 60(9):1411-7.
    View in: PubMed
    Score: 0.006
  44. Exonic deletions in AUTS2 cause a syndromic form of intellectual disability and suggest a critical role for the C terminus. Am J Hum Genet. 2013 Feb 07; 92(2):210-20.
    View in: PubMed
    Score: 0.006
  45. Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia. Blood. 2012 Jul 26; 120(4):833-42.
    View in: PubMed
    Score: 0.006
  46. Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder. Am J Hum Genet. 2011 Oct 07; 89(4):551-63.
    View in: PubMed
    Score: 0.006
  47. Maternal uniparental disomy of chromosome 4 in a patient with limb-girdle muscular dystrophy 2E confirmed by SNP array technology. Clin Genet. 2012 Jun; 81(6):578-83.
    View in: PubMed
    Score: 0.006
  48. Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D. Ann Neurol. 2010 Nov; 68(5):629-38.
    View in: PubMed
    Score: 0.005
  49. Novel diagnostic features of dysferlinopathies. Muscle Nerve. 2010 Jul; 42(1):14-21.
    View in: PubMed
    Score: 0.005
  50. Apolipoprotein E4 as a predictor of outcomes in pediatric mild traumatic brain injury. J Neurotrauma. 2009 Sep; 26(9):1489-95.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.